Offshore trusts are costly, potentially risky

Q.I've been hearing and reading a lot about offshore trusts as a way of protecting assets. Do they really work?

Related Videos
Related Content

New TMB-001 Sub-Analysis Data Published in Clinical and Experimental Dermatology

March 22nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

AAD 2023 Pearls from Zoe Diana Draelos, MD

March 22nd 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Phase 3 Data for Bimekizumab Shows Well Maintained Response

March 21st 2023

25.1% of Patients Cited “Less Noticeable” Vitiligo in Recent Study

March 21st 2023

New TMB-001 Sub-Analysis Data Published in Clinical and Experimental Dermatology

March 22nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

AAD 2023 Pearls from Zoe Diana Draelos, MD

March 22nd 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Phase 3 Data for Bimekizumab Shows Well Maintained Response

March 21st 2023

25.1% of Patients Cited “Less Noticeable” Vitiligo in Recent Study

March 21st 2023

New TMB-001 Sub-Analysis Data Published in Clinical and Experimental Dermatology

March 22nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

AAD 2023 Pearls from Zoe Diana Draelos, MD

March 22nd 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Phase 3 Data for Bimekizumab Shows Well Maintained Response

March 21st 2023

25.1% of Patients Cited “Less Noticeable” Vitiligo in Recent Study

March 21st 2023
© 2023 MJH Life Sciences

All rights reserved.